[go: up one dir, main page]

GB1069144A - Method for the treatment of malignant tumors - Google Patents

Method for the treatment of malignant tumors

Info

Publication number
GB1069144A
GB1069144A GB27185/64A GB2718564A GB1069144A GB 1069144 A GB1069144 A GB 1069144A GB 27185/64 A GB27185/64 A GB 27185/64A GB 2718564 A GB2718564 A GB 2718564A GB 1069144 A GB1069144 A GB 1069144A
Authority
GB
United Kingdom
Prior art keywords
ethyleneimino
spores
injection
administered
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27185/64A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1069144A publication Critical patent/GB1069144A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N3/00Spore forming or isolating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method of treating malignant tumours in vertebrates other than human beings comprises parenterally administering to such vertebrates spores of a non-pathogenic, anaerobic strain of a microorganism of the genus Clostridium capable of localising in tumours and causing oncolysis thereof in conjunction with an anti-tumour chemotherapeutic agent selected from 5-fluoro-deoxyuridine or an alkylating agent of the ethyleneimino type, the latter being administered so as to be present in the animal body during the time of maximum oncolytic effect of the spores. Preferred alkylating agents of the ethyleneimino type are Mitomycin C, sec-1-ethyleneimino-2-hydroxy-butane, 2,5-bis (ethyleneimino)-3,6-bis-propoxy-1,4-benzoquinone, and 2,3,5-tris-ethyleneimino-1,4-benzoquinone. The anti-tumour agent may be administered 1-3 days after injection of spores, or 1-3 days prior to spore injection to build up a body level, followed by lower maintenance doses after injection of spores. The p anti-tumour agents may be administered dissolved or suspended in physiologically acceptable diluents or carriers.
GB27185/64A 1963-07-10 1964-07-01 Method for the treatment of malignant tumors Expired GB1069144A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29418563A 1963-07-10 1963-07-10

Publications (1)

Publication Number Publication Date
GB1069144A true GB1069144A (en) 1967-05-17

Family

ID=23132267

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27185/64A Expired GB1069144A (en) 1963-07-10 1964-07-01 Method for the treatment of malignant tumors

Country Status (3)

Country Link
BE (1) BE650279A (en)
FR (1) FR6631M (en)
GB (1) GB1069144A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1716858A2 (en) 1999-09-17 2006-11-02 Wellstat Biologics Corporation Oncolytic virus
US7470426B1 (en) 1997-10-09 2008-12-30 Wellstat Biologics Corporation Treatment of neoplasms with viruses
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
US8043612B2 (en) 1997-10-09 2011-10-25 Wellstat Biologics Corporation Infection and treatment of neoplasms with vesicular stomatitis virus
US8105578B2 (en) 1997-10-09 2012-01-31 Wellstat Biologics Corporation Treatment of neoplasms with viruses
US8147822B1 (en) 1999-09-17 2012-04-03 Wellstat Biologics Corporation Oncolytic virus
CN103374538A (en) * 2012-04-27 2013-10-30 格里菲斯大学 Compositions comprising derived bacterial strains of Clostridium ghonii and methods of use thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470426B1 (en) 1997-10-09 2008-12-30 Wellstat Biologics Corporation Treatment of neoplasms with viruses
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
US8043612B2 (en) 1997-10-09 2011-10-25 Wellstat Biologics Corporation Infection and treatment of neoplasms with vesicular stomatitis virus
US8105578B2 (en) 1997-10-09 2012-01-31 Wellstat Biologics Corporation Treatment of neoplasms with viruses
EP1716858A2 (en) 1999-09-17 2006-11-02 Wellstat Biologics Corporation Oncolytic virus
US8147822B1 (en) 1999-09-17 2012-04-03 Wellstat Biologics Corporation Oncolytic virus
CN103374538A (en) * 2012-04-27 2013-10-30 格里菲斯大学 Compositions comprising derived bacterial strains of Clostridium ghonii and methods of use thereof
EP2841558A4 (en) * 2012-04-27 2015-11-04 Univ Griffith ONCOLYTIC GHONII CLOSTRIDIUM STRAINS AND METHODS OF MAKING AND USING THE SAME

Also Published As

Publication number Publication date
FR6631M (en) 1969-01-20
BE650279A (en) 1965-01-08

Similar Documents

Publication Publication Date Title
GB1424456A (en) Magnetic medical treatment device
ES2071484T3 (en) DERIVATIVES OF 2,4-DIAMINOQUINAZOLINAS TO INCREASE ANTITUMORAL ACTIVITY.
GB1382056A (en) Moulding apparatus
GB1069144A (en) Method for the treatment of malignant tumors
GB985568A (en) Improvements in or relating to mills
GB1440478A (en) 4-thiopyrimido-4,5-d-pyrimidines
GB1203009A (en) Rubber with improved green strength
GB1205966A (en) 4'-DEMETHYL-EPIPODOPHYLLOTOXIN-beta-D-ETHYLIDENE-GLUCOSIDE
FR2219159A1 (en) Adamantane nitroxide radicals - antiviral and anticancer agents, also useful in nuclear resonance magnetometry
ES392531A1 (en) Process for preparing vicinal glycols from olefins
ES353533A1 (en) Tetanus vaccine and process for preparing it
USD149579S (en) Inflatable swim support or similar article
GB1067194A (en) Improvements in or relating to rotary feeders
GB788228A (en) Improvements in or relating to coffins
ES425444A1 (en) Bis-(polyhalogenoanilino)-anthraquinones
GB970365A (en) Preparations for the treatment of tumours
GB999705A (en) Improvements in or relating to crop guides
GB622519A (en) Improvements in or relating to gate and door supports
FR2059480A1 (en) Anticarcinogenic compns contng vitamin a - acids
FR2150621A2 (en) Amino-derivs of phloroglucinol - with antiarrhythmic activity
FR2052116A5 (en) Anti-oxidant bisphenols prodn
Assembly Providing for Signatures on Warrants Drawn on the State Board of Agriculture for the Fort Lewis Agricultural and Mechanical College.
FR2047870A1 (en) Tetracyclins derivs for use as antibiotics
GB996922A (en) Improvements in or relating to tedders
ES257181A1 (en) New antibiotic